A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

A new study reveals a shocking jump in “biological age” among Gen-X, Millennials, and Gen-Z—and it might explain the rise in early-onset cancers.

A risk model that combines a mammographic artificial intelligence (AI) risk score with polygenic and clinical risk scores ...

InterVenn Biosciences, a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions, and Aranscia, a global provider of award-winning ...

Cancer is one of the leading causes of death and disability, affecting millions of working-age adults and their families each ...

Data presented during ICCBH 2026 showed that improvements in tibial-femoral angle (TFA), a measure of lower extremity alignment, continued ...

A quantum-inspired AI approach can analyze millions of molecular features from small datasets, improving predictions, ...

PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...

We look at power, speed, calories, recovery, fuelling and more to compare a Tour de France rider's efforts to those of an ...

NetraMark Holdings Inc. (the "Company" or "NetraMark") , an artificial intelligence (AI) company that is transforming ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its clinical development programs for the treatment of children with achondroplasia will be shared in an oral presentation ...

The link between biological aging and early-onset cancer risk offers crucial insights into generational health trends and ...